Advanced Ros1 Positive Non Small Cell Lung Cancer clinical trials

Explore recruiting advanced ros1 positive non small cell lung cancer clinical trials.

Recruiting advanced ros1 positive non small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Ros1 Positive Non Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IFCT-2003 ALBATROS A phase II single-group assignment, multicenter study of efficacy and safety of lorlatinib monotherapy after failure of first-line tyrosine kinase inhibitor in patients with advanced ROS1-positive non-small cell lung cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Ros1 Positive Non Small Cell Lung Cancer trials by city

Advanced Ros1 Positive Non Small Cell Lung Cancer in Toronto Advanced Ros1 Positive Non Small Cell Lung Cancer in Vancouver Advanced Ros1 Positive Non Small Cell Lung Cancer in Montreal Advanced Ros1 Positive Non Small Cell Lung Cancer in Calgary Advanced Ros1 Positive Non Small Cell Lung Cancer in Edmonton Advanced Ros1 Positive Non Small Cell Lung Cancer in Ottawa Advanced Ros1 Positive Non Small Cell Lung Cancer in Winnipeg Advanced Ros1 Positive Non Small Cell Lung Cancer in Quebec City Advanced Ros1 Positive Non Small Cell Lung Cancer in Hamilton Advanced Ros1 Positive Non Small Cell Lung Cancer in Kitchener Advanced Ros1 Positive Non Small Cell Lung Cancer in London Advanced Ros1 Positive Non Small Cell Lung Cancer in Halifax Advanced Ros1 Positive Non Small Cell Lung Cancer in New York Advanced Ros1 Positive Non Small Cell Lung Cancer in Los Angeles Advanced Ros1 Positive Non Small Cell Lung Cancer in Chicago Advanced Ros1 Positive Non Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease